Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.
Tianjin Chase Sun Pharmaceutical Dividend Announcement
• Tianjin Chase Sun Pharmaceutical announced a annually dividend of ¥0.03 per ordinary share which will be made payable on 2024-05-23. Ex dividend date: 2024-05-23
• Tianjin Chase Sun Pharmaceutical annual dividend for 2024 was ¥0.03
• Tianjin Chase Sun Pharmaceutical annual dividend for 2023 was ¥0.03
• Tianjin Chase Sun Pharmaceutical's trailing twelve-month (TTM) dividend yield is 0.76%
• Tianjin Chase Sun Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 118.18%
• Tianjin Chase Sun Pharmaceutical's dividend growth over the last five years (2018-2023) was 8.45% year
• Tianjin Chase Sun Pharmaceutical's dividend growth over the last ten years (2013-2023) was -11.34% year
Tianjin Chase Sun Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-23 | ¥0.03 | annually | 2024-05-23 |
2023-05-12 | ¥0.03 | annually | 2023-05-12 |
2022-05-19 | ¥0.04 | annually | 2022-05-19 |
2021-06-10 | ¥0.04 | annually | 2021-06-10 |
2020-06-01 | ¥0.05 | annually | 2020-06-01 |
2019-05-16 | ¥0.02 | annually | 2019-05-16 |
2018-05-18 | ¥0.02 | annually | 2018-05-18 |
2017-05-24 | ¥0.03 | annually | 2017-05-24 |
2016-05-25 | ¥0.06 | annually | |
2015-05-26 | ¥0.10 | annually | |
2014-05-19 | ¥0.10 | annually | |
2013-05-07 | ¥0.10 | annually |
Tianjin Chase Sun Pharmaceutical Dividend per year
Tianjin Chase Sun Pharmaceutical Dividend growth
Tianjin Chase Sun Pharmaceutical Dividend Yield
Tianjin Chase Sun Pharmaceutical current trailing twelve-month (TTM) dividend yield is 0.76%. Interested in purchasing Tianjin Chase Sun Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Tianjin Chase Sun Pharmaceutical Financial Ratios
Tianjin Chase Sun Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Tianjin Chase Sun Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tianjin Chase Sun Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tianjin Chase Sun Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tianjin Chase Sun Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tianjin Chase Sun Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tianjin Chase Sun Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tianjin Chase Sun Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tianjin Chase Sun Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tianjin Chase Sun Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tianjin Chase Sun Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tianjin Chase Sun Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.